On 14 March, the EU and its partners will host a side event in the margins of the 66^th Session of the United Nations Commission on Narcotic Drugs, entitled ‘Progress in addressing the evolution of illicit drug manufacture’.

Illicit drug manufacture continues to increase in extent, diversity and efficiency. This especially applies to the manufacture of synthetic drugs. Last year’s CND resolution 65/3 called upon Member States to intensify efforts to address the diversion of non-scheduled chemicals frequently used in the illicit manufacture of drugs and the proliferation of designer precursors. The resolution also outlined opportunities for proactive interventions and a number of tools and practical approaches.

This side event will therefore discuss good practices, approaches and experiences in addressing illicit drug manufacture, in particular regarding designer precursors and innovative ways of scheduling.

More information on the 66^th Session of the United Nations Commission on Narcotic Drugs is available here.

Follow the event online here

General publications8 March 2023

Progress in addressing the evolution of illicit drug manufacture - Flyer

English

(3.73 MB - PDF)

Download